These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2779 related items for PubMed ID: 19903804

  • 1. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.
    J Natl Cancer Inst; 2009 Dec 02; 101(23):1612-23. PubMed ID: 19903804
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
    Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J, New Technologies for Cervical Cancer Working Group.
    J Natl Cancer Inst; 2006 Jun 07; 98(11):765-74. PubMed ID: 16757701
    [Abstract] [Full Text] [Related]

  • 4. Re: Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Lynge E, Rebolj M.
    J Natl Cancer Inst; 2010 May 19; 102(10):739; author reply 739-40. PubMed ID: 20360534
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.
    J Natl Cancer Inst; 2009 Jan 21; 101(2):88-99. PubMed ID: 19141778
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening.
    Kotaniemi-Talonen L, Malila N, Nieminen P, Anttila A, Tarkkanen J, Laurila P, Hakama M.
    Int J Cancer; 2008 Dec 15; 123(12):2902-6. PubMed ID: 18792100
    [Abstract] [Full Text] [Related]

  • 10. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
    Porras C, Wentzensen N, Rodríguez AC, Morales J, Burk RD, Alfaro M, Hutchinson M, Herrero R, Hildesheim A, Sherman ME, Wacholder S, Solomon D, Schiffman M.
    Int J Cancer; 2012 Apr 15; 130(8):1879-87. PubMed ID: 21607948
    [Abstract] [Full Text] [Related]

  • 11. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 15; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ.
    Lancet Oncol; 2012 Jan 15; 13(1):78-88. PubMed ID: 22177579
    [Abstract] [Full Text] [Related]

  • 13. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G, Biggeri A, Confortini M, Naldoni C, Segnan N, Sideri M, Zappa M, Zorzi M, Calvia M, Accetta G, Giordano L, Cogo C, Carozzi F, Gillio Tos A, Arbyn M, Mejier CJ, Snijders PJ, Cuzick J, Giorgi Rossi P.
    Epidemiol Prev; 2012 Jan 15; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [Abstract] [Full Text] [Related]

  • 14. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
    Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, De Marco L, Giorgi-Rossi P, Pontenani G, Rosso S, Sani C, Sintoni C, Segnan N, Zorzi M, Cuzick J, Rizzolo R, Ronco G, New Technologies for Cervival Cancer Screening (NTCC) Working Group.
    Lancet Oncol; 2008 Oct 15; 9(10):937-45. PubMed ID: 18783988
    [Abstract] [Full Text] [Related]

  • 15. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
    Thomsen LT, Kjaer SK, Munk C, Ørnskov D, Waldstrøm M.
    Acta Obstet Gynecol Scand; 2021 Mar 15; 100(3):394-402. PubMed ID: 33566361
    [Abstract] [Full Text] [Related]

  • 16. Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.
    Bergeron C, Giorgi-Rossi P, Cas F, Schiboni ML, Ghiringhello B, Dalla Palma P, Minucci D, Rosso S, Zorzi M, Naldoni C, Segnan N, Confortini M, Ronco G.
    J Natl Cancer Inst; 2015 Feb 15; 107(2):. PubMed ID: 25568167
    [Abstract] [Full Text] [Related]

  • 17. HPV testing with cytology triage for cervical cancer screening in routine practice.
    Louvanto K, Chevarie-Davis M, Ramanakumar AV, Franco EL, Ferenczy A.
    Am J Obstet Gynecol; 2014 May 15; 210(5):474.e1-7. PubMed ID: 24373948
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ.
    Cochrane Database Syst Rev; 2013 Mar 28; 2013(3):CD008054. PubMed ID: 23543559
    [Abstract] [Full Text] [Related]

  • 19. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr 28; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 20. Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study.
    Ogilvie GS, Krajden M, van Niekerk DJ, Martin RE, Ehlen TG, Ceballos K, Smith LW, Kan L, Cook DA, Peacock S, Stuart GC, Franco EL, Coldman AJ.
    Br J Cancer; 2012 Dec 04; 107(12):1917-24. PubMed ID: 23169286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 139.